UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 46

of 'Cancer of the appendix and pseudomyxoma peritonei'

46
TI
[Pseudomyxoma peritonei: new concept and new therapeutic approach].
AU
Loungnarath R, Causeret S, Brigand C, Gilly FN, Glehen O
SO
Ann Chir. 2005;130(2):63.
 
Pseudomyxoma peritonei is a rare disease, usually diagnosed after the discover of "jelly belly" by laparotomy. With the progress of immunohistochemistry, most authors now acknowledge the appendix to be the principal origin of this disease. Pseudomyxoma peritonei need to considered as border line malignant disease because of its inevitable persistence and progression without adapted therapeutic approach: cytoreductive surgery combined with perioperative intraperitoneal chemotherapy (intraperitoneal chemohyperthermia and/or immediate postoperative intraperitoneal chemotherapy) into specialized centres. The principal prognostic factors are the prior surgical history, the completeness of cytoreduction and especially the histopathologic grade.
AD
Département de chirurgie colorectale, centre hospitalier de l'universitéde montréal, hôpital Saint-Luc, Montréal, Québec, Canada.
PMID